Ratings for Omega Therapeutics (NASDAQ:OMGA) were provided by 6 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.
Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 4 | 2 | 0 | 0 | 0 |
| Last 30D | 0 | 1 | 0 | 0 | 0 |
| 1M Ago | 0 | 0 | 0 | 0 | 0 |
| 2M Ago | 3 | 0 | 0 | 0 | 0 |
| 3M Ago | 1 | 1 | 0 | 0 | 0 |
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $9.83, with a high estimate of $12.00 and a low estimate of $7.00. This current average has decreased by 4.1% from the previous average price target of $10.25.
Understanding Analyst Ratings: A Comprehensive Breakdown
The standing of Omega Therapeutics among financial experts becomes clear with a...
Login or create a forever free account to read this news
Sign up/Log in